肿瘤相关成纤维细胞在乳腺癌发生发展及耐药中的作用

摘要/Abstract

中图分类号:

R737.9

田庄, 李晓菊, 罗嘉嘉, 黄平, 郭虎, 高源. 肿瘤相关成纤维细胞在乳腺癌发生发展及耐药中的作用[J]. 承德医学院学报, 2020, 37(5): 410-414.

[1] Anderson BO, Cazap E, Saghir NSE, et al.Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010[J]. Lancet Oncol, 2011,12(4): 387-398.
[2] DeSantis CE, Ma J, Goding SA, et al. Breast cancer statistics,2017, racial disparity in mortality by state[J]. CA Cancer J Clin, 2017, 67(6): 439-448.
[3] Fan L, Strasser-Weippl K, Li JJ, et al.Breast cancer in China[J].Lancet Oncol, 2014, 15(7): e279-e289.
[4] Waks AG,Winer EP.Breast Cancer Treatment:A Review[J].JAMA, 2019, 321(3): 288-300.
[5] Deng C, Zhang Q, Jia M, et al.Tumors and Their Microenvironment Dual-Targeting Chemotherapy with Local Immune Adjuvant Therapy for Effective Antitumor Immunity against Breast Cancer[J]. Adv Sci (Weinh), 2019, 6(6): 1801868.
[6] Wu T, Dai Y.Tumor microenvironment and therapeutic response[J]. Cancer Lett, 2017, 387: 61-68.
[7] Ershaid N, Sharon Y, Doron H, et al.NLRP3 inflammasome in fibroblasts links tissue damage with inflammation in breast cancer progression and metastasis[J]. Nat Commun, 2019, 10(1): 4375.
[8] Qin X, Guo H, Wang X, et al.Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5[J]. Genome Biol, 2019, 20(1):12.
[9] Chen X, Song E.Turning foes to friends: targeting cancer-associated fibroblasts[J]. Nat Rev Drug Discov, 2019, 18(2): 99-115.
[10] Houthuijzen JM, Jonkers J.Cancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment[J]. Cancer and Metastasis Reviews, 2018, 37(4): 577-597.
[11] Rhim AD, Oberstein PE, Thomas DH, et al.Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma[J].Cancer Cell, 2014, 25(6): 735-747.
[12] Sahai E, Astsaturov I, Cukierman E, et al.A framework for advancing our understanding of cancer-associated fibroblasts[J].Nat Rev Cancer, 2020, 20(3): 174-186.
[13] Martens JW, Sieuwerts AM, Bolt-deVries J, et al. Aging of stromal-derived human breast fibroblasts might contribute to breast cancer progression[J]. ThrombHaemost, 2003, 89(2): 393-404.
[14] Palmieri C, Roberts-Clark D, Assadi-Sabet A, et al.Fibroblast growth factor 7, secreted by breast fibroblasts, is an interleukin-1beta-induced paracrine growth factor for human breast cells[J]. J Endocrinol, 2003, 177(1): 65-81.
[15] Locatelli A, Lofgren KA, Daniel AR, et al.Mechanisms of HGF/Met signaling to Brk and Sam68 in breast cancer progression[J].Horm Cancer, 2012, 3(1-2): 14-25.
[16] Kojima Y, Acar A, Eaton EN, et al.Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts[J]. Proc Natl Acad Sci USA, 2010, 107(46): 20009-20014.
[17] Orimo A, Gupta PB, Sgroi DC, et al.Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion[J]. Cell, 2005, 121(3): 335-348.
[18] Sasano H, Miki Y, Shibuya R, et al.Aromatase and in situ estrogen production in DCIS (ductal carcinoma in situ) of human breast[J]. J Steroid Biochem Mol Biol, 2010, 118(4-5): 242-245.
[19] Yu Y, Xiao CH, Tan LD, et al.Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-beta signalling[J]. Br J Cancer, 2014, 110(3): 724-732.
[20] Lee KW, Yeo SY, Sung CO, et al.Twist1 is a key regulator of cancer-associated fibroblasts[J]. Cancer Res, 2015, 75(1): 73-85.
[21] Al-Ansari MM, Hendrayani SF, Shehata AI, et al.p16(INK4A) represses the paracrine tumor- promoting effects of breast stromal fibroblasts[J]. Oncogene, 2013, 32(18): 2356-2364.
[22] Yu Y, Xiao CH, Tan LD, et al.Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-beta signalling[J]. Br J Cancer, 2014, 110(3): 724-732.
[23] Kessenbrock K, Plaks V, Werb Z.Matrix metalloproteinases: regulators of the tumor microenvironment[J]. Cell, 2010, 141(1): 52-67.
[24] Choi YP, Lee JH, Gao MQ, et al.Cancer-associated fibroblast promote transmigration through endothelial brain cells in three-dimensional in vitro models[J]. Int J Cancer, 2014, 136(9): 2024-2033.
[25] Maeda T, Desouky J, Friedl A.Syndecan-1 expression by stromal
[26] fibroblasts promotes breast carcinoma growth in vivo and stimulates tumor angiogenesis[J]. Oncogene, 2006, 25(9):1408-1412.
[27] Orimo A, Gupta PB, Sgroi DC, et al.Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion[J]. Cell, 2005, 121(3): 335-348.
[28] Ranogajec I, Jakic-Razumovic J, Puzovic V, et al.Prognostic value of matrix metalloproteinase- 2(MMP-2), matrix metalloproteinase-9(MMP-9) and aminopeptidase N/CD13 in breast cancer patients[J]. Med Oncol, 2012, 29(2): 561-569.
[29] Gao Y, Wang Z, Hao Q, et al.Loss of ERα induces amoeboid-like migration of breast cancer cells by downregulating vinculin[J].Nature Communications, 2017, 8(1): 14483.
[30] Patel HK, Bihani T.Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment[J]. Pharmacol Ther, 2018,186: 1-24.
[31] Li K, Kang H, Wang Y, et al.Letrozole-induced functional changes in carcinoma-associated fibroblasts and their influence on breast cancer cell biology[J]. Med Oncol, 2016, 33(7): 64.
[32] Roswall P, Bocci M, Bartoschek M, et al.Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling[J]. Nat Med, 2018, 24(4): 463-473.
[33] Sun X, Mao Y, Wang J, et al.IL-6 secreted by cancer-associated fibroblasts induces tamoxifen resistance in luminal breast cancer[J]. Oncogene, 2014, 33(35): 4450.
[34] Sansone P, Savini C, Kurelac I, et al.Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer[J]. Proc Natl Acad Sci USA, 2017, 114(43): E9066-E9075.
[35] Dittmer A, Dittmer J.Long-term exposure to carcinoma-associated fibroblasts makes breast cancer cells addictive to integrin beta1[J].Oncotarget, 2018, 9(31): 22079-22094.
[36] Valkenburg KC, de Groot AE, Pienta KJ. Targeting the tumour stroma to improve cancer therapy[J]. Nat Rev Clin Oncol, 2018, 15(6): 366-381.
[37] Zeng C, Fan D, Xu Y, et al.Curcumol enhances the sensitivity of doxorubicin in triple-negative breast cancer via regulating the miR-181b-2-3p-ABCC3 axis[J]. Biochem Pharmacol, 2020, 174: 113795.
[38] Li CW, Lim SO, Chung EM, et al.Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1[J]. Cancer Cell, 2018, 33(2): 187-201.
[39] Emens LA.Breast Cancer Immunotherapy: Facts and Hopes[J].Clin Cancer Res, 2018, 24(3): 511-520.
[40] Li CW, Lim SO, Chung EM, et al.Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1[J]. Cancer Cell, 2018, 33(2): 187-201.
[41] Li X, Wetherilt CS, Krishnamurti U, et al.Stromal PD-L1 Expression Is Associated With Better Disease-Free Survival in Triple-Negative Breast Cancer[J]. Am J Clin Pathol, 2016, 146(4): 496-502.
[42] Liu T, Han C, Wang S, et al.Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy[J]. J Hematol Oncol, 2019, 12(1): 86.
[43] Huang JY, Cheng YJ, Lin YP, et al.Extracellular matrix of glioblastoma inhibits polarization and transmigration of T cells: the role of tenascin-C in immune suppression[J]. J Immunol, 2010, 185(3): 1450-1459.
[44] Tsunoda T, Inada H, Kalembeyi I, et al.Involvement of large tenascin-C splice variants in breast cancer progression[J]. Am J Pathol, 2003, 162(6): 1857-1867.
[45] Xu K, Rajagopal S, Klebba I, et al.The role of fibroblast Tiam1 in tumor cell invasion and metastasis[J]. Oncogene, 2010, 29(50): 6533-6542.
[46] Chang PH, Hwang-Verslues WW,Chang YC, et al.Activation of Robo1 signaling of breast cancer cells by Slit2 from stromal fibroblast restrains tumorigenesis via blocking PI3K/Akt/ beta- catenin pathway[J]. Cancer Res, 2012, 72(18): 4652-4661.

肿瘤相关成纤维细胞在乳腺癌发生发展及耐药中的作用

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	林美红, 张玮琳, 谢碧珊. 优质护理对乳腺癌患者术后生活质量和满意度的影响[J]. 承德医学院学报, 2021, 38(3): 228-230.
[2]	张娟. 风险护理管理对早期乳腺癌NAC根治术后即刻乳房再造的作用[J]. 承德医学院学报, 2021, 38(3): 231-233.
[3]	任悦菲, 刘克温, 李青, 田建丽. 移动健康对乳腺癌术后患者生活质量影响Meta分析[J]. 承德医学院学报, 2020, 37(6): 529-532.
[4]	钮淋, 刘镭, 程露阳, 许倩, 陈志宏, 乔跃兵. 基于生物信息学筛选三阴性乳腺癌关键基因和通路[J]. 承德医学院学报, 2020, 37(5): 361-368.
[5]	荆菁华. Xpert MTB/RIF技术对结核分枝杆菌的检测及耐药性研究[J]. 承德医学院学报, 2020, 37(5): 385-387.
[6]	刘春芳, 王孜恒, 芮文科, 黄云侠, 徐莹, 季红敏. 多元化延续护理对乳腺癌术后患者自我护理能力及焦虑抑郁情绪的影响[J]. 承德医学院学报, 2020, 37(5): 398-399.
[7]	刘赛璇, 薛晶, 周丽丽, 赵杨, 申兴斌. 鬼臼苦素对人乳腺癌MCF-7细胞增殖的抑制作用[J]. 承德医学院学报, 2020, 37(1): 5-7.
[8]	郭奕嫱, 徐萌泽, 辛小林, 田建丽, 刘亚莉, 刘洋. 乳房自检态度量表的信效度检验[J]. 承德医学院学报, 2020, 37(1): 82-84.
[9]	黄艳洁, 袁亚男, 李璐, 许倩, 郑纪宁. miR-15a-5p和MDR1在大肠癌组织中的表达及临床意义^*[J]. 承德医学院学报, 2019, 36(6): 455-458.
[10]	沙文光, 戴本启, 叶发展. 儿童重症社区获得性肺炎病原体分布及细菌耐药情况分析[J]. 承德医学院学报, 2019, 36(1): 24-27.
[11]	陈泽城, 邱振华, 周惠娜, 吴红梅. 肿瘤患者感染肺炎克雷伯菌常见产酶的检测及耐药性分析^*[J]. 承德医学院学报, 2018, 35(6): 469-472.
[12]	魏萌, 司丽娜, 陈磊, 程露阳, 杨松鹤. 瘦素对人乳腺癌MCF-7细胞DMBT1表达的影响^*[J]. 承德医学院学报, 2018, 35(3): 252-253.
[13]	薛晶, 赵杨, 程玉, 徐树蕾, 严鹏, 申兴斌. IGF-1在乳腺癌中的表达与临床意义[J]. 承德医学院学报, 2018, 35(2): 99-101.
[14]	张洋洋, 梁丽玲. 医院获得性肠球菌属细菌感染的分布特征及耐药性分析[J]. 承德医学院学报, 2018, 35(2): 101-104.
[15]	王芸, 陈淑如. 保乳根治术和改良根治术治疗Ⅰ,Ⅱ期乳腺癌的效果和安全性分析^*[J]. 承德医学院学报, 2018, 35(1): 32-34.